A detailed history of Dt Investment Partners, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Dt Investment Partners, LLC holds 44 shares of VRTX stock, worth $22,736. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44
Previous 15 193.33%
Holding current value
$22,736
Previous $7,000 185.71%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$460.0 - $505.78 $13,340 - $14,667
29 Added 193.33%
44 $20,000
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $4,107 - $4,582
15 New
15 $4,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $133B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Dt Investment Partners, LLC Portfolio

Follow Dt Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dt Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dt Investment Partners, LLC with notifications on news.